Lianhua Qingwen Capsule has the functions of clearing away heat and toxic materials, dispersing lung qi and clearing heat. Can be used for treating influenza with heat toxin invading lung syndrome. Symptoms are fever or high fever, aversion to cold, muscle aches, nasal congestion and runny nose, cough, headache, dry throat and sore throat, red tongue, yellow or greasy fur, etc.

National medical insurance category A (version 20 19); National list of essential drugs; Protected varieties of traditional Chinese medicine.

In February, 2020, Lianhua Qingwen Capsule (granule) was included in the diagnosis and treatment plan of novel coronavirus of the National Health and Wellness Committee (the 6th version was tried out).

In April, 2020, the Approval Document of Drug Supplement Application issued by the State Administration of Pharmaceutical Products showed that Lianhua Qingwen Capsule (granule) produced by Yiling Pharmaceutical was approved to be used for fever, cough and fatigue caused by mild and common viral pneumonia in COVID-19, and the course of treatment was 7 to 10 day.

At present, the listed company producing Lianhua Qingwen Capsule is Yiling Pharmaceutical (stock code: 002603).

Response time: August 7, 2020. Please refer to the latest business changes announced by Ping An Bank in official website.

[Ping An Car Owner Loan] A car can be loaned up to 500,000 yuan.

/station/activity/loan/QR-Carlo an/loan trust . html？ source = sa0000632 & ampouterSource = bdzdhhr _ zscd & ampouterid = ou0000250 & ampcid = bdzdhhr _ zscd & ampdownapp_id=AM00 1000065